Edwards Lifesciences Sapien 3 Ultra TAVR

Edwards Lifesciences’ Sapien 3 Ultra TAVR [Image courtesy of Edwards Lifesciences]

Researchers published a paper in the Journal of the American Medical Association citing insufficient evidence regarding the superiority of TAVR devices.

Currently, only three TAVR devices are commercially available in the U.S., belonging to Edwards Lifesciences (NYSE:EW), Medtronic (NYSE:MDT) and Boston Scientific (NYSE:BSX), although several others are being used in clinical trials to evaluate safety and efficacy.

Get the full story at our sister site, Medical Design & Outsourcing.